Works matching IS 00016837 AND DT 2023 AND VI 80 AND IP 5

Results: 10

HYPOGLYCEMIC EFFECT OF BETULIN IN RATS WITH EXPERIMENTAL DIABETES.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 795, doi. 10.32383/appdr/172620
By:
- ZAKRZESKA, AGNIESZKA;
- KITLAS, PAWEŁ;
- SHLYAHTUN, ALEXIEJ;
- KRASIŃSKA, NATALIA;
- JABŁOŃSKI, RYSZARD;
- TOMULEWICZ, MIKOŁAJ
Publication type:
Article
SYNTHESIS, ANTIVIRAL AND CYTOSTATIC ACTIVITY OF NEW SERIES OF NAPHTHALIMIDE DERIVATIVES.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 775, doi. 10.32383/appdr/171434
By:
- GAWRON, KATARZYNA;
- PIOTROWSKA, DOROTA G.;
- ANDREI, GRACIELA;
- SCHOLS, DOMINIQUE;
- SNOECK, ROBERT;
- GŁOWACKA, IWONA E.
Publication type:
Article
COMPATIBILITY STUDY OF KETOPROFEN WITH SELECTED EXCIPIENTS USED IN SOLID DOSAGE FORMS: EXPERIMENTAL DESIGN APPROACH.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 717, doi. 10.32383/appdr/172622
By:
- RONOWICZ-PILARCZYK, JOANNA
Publication type:
Article
ANTIOXIDANT ACTIVITY OF POLYSACCHARIDES FROM NATURAL SOURCES.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 705, doi. 10.32383/appdr/173189
By:
- PANPAN WEI;
- MENGYUE DENG;
- YUZHEN DING;
- DIE XIA;
- ZIJUN YAN;
- TONG CHEN
Publication type:
Article
INTERACTION OF PUFAS AND DOXORUBICIN: THE ENHANCED TOXICITY IN BREAST CANCER CELLS.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 747, doi. 10.32383/appdr/171546
By:
- ZAJDEL, ALICJA;
- WILCZOK, ADAM
Publication type:
Article
(E)-3-(4-(TERT-BUTYL)PHENYL)-N-ISOBUTYL-2-METHYLACRYLAMIDE SUPPRESSES ADIPOGENESIS IN HIGH-FAT-FED MICE SUPPRESSES ADIPOGENESIS IN HIGH-FAT-FED MICE.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 737, doi. 10.32383/appdr/171509
By:
- JINYOUNG HUR;
- SANGHEE KIM;
- BO-RA YOON;
- GUIJAE YOO;
- INWOOK CHOI;
- HO-YOUNG PARK;
- SANG YOON CHOI
Publication type:
Article
STABILITY OF API AS A KEY PARAMETER FOR NEW FORMULATION DEVELOPMENT -- A CASE STUDY OF ROSUVASTATIN CALCIUM.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 723, doi. 10.32383/appdr/174028
By:
- SIP, SZYMON;
- ZALEWSKI, PRZEMYSŁAW;
- PAŁUBICKA, ANNA;
- CIELECKA-PIONTEK, JUDYTA
Publication type:
Article
NOVEL CDK4/6 INHIBITOR -- WXJ-8 -- EXERTS ANTI-EFFECTS THROUGH CELL CYCLE IN BREAST CANCER.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 763, doi. 10.32383/appdr/173986
By:
- JING JI;
- JIN-QING HAN;
- XIAO HOU;
- ZHEN ZHANG;
- GUAN-CHUN LI;
- LING-YI ZUO;
- JIAO-JIAO ZHOU;
- XIU-JUN WANG;
- SHAO-JIE MA;
- BIN LIU
Publication type:
Article
SYNTHESIS AND VERIFICATION OF A NOVEL ATTAINABLE TUMOR TARGETING MAGNETIC NANOPARTICLE.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 755, doi. 10.32383/appdr/173984
By:
- JIASHENG YAN;
- YINGXIU CHEN
Publication type:
Article
POLYCYSTIC OVARY SYNDROME (PCOS) -- THE APPLICATION OF SELECTED OFF-LABEL DRUGS FOUND IN MEDICAL DATABASES.
Published in:
Acta Poloniae Pharmaceutica, 2023, v. 80, n. 5, p. 695, doi. 10.32383/appdr/172065
By:
- KUS, KRZYSZTOF;
- SYGIT, MARIA;
- MACIUSZEK-BARTKOWSKA, BARBARA;
- RATAJCZAK, PIOTR;
- PACZKOWSKA, ANNA;
- KOPCIUCH, DOROTA;
- ZAPRUTKO, TOMASZ
Publication type:
Article